Table 1.
Clinical characteristics of the 271 patients with adnexal masses.
| Patients with an adnexal mass | ||||
|---|---|---|---|---|
| (n = 271) | ||||
| Benign mass | Borderline carcinoma | Invasive carcinoma | Metastatic tumor | |
| (n = 130) | (n = 41) | (n = 92) | (n = 8) | |
| Age (in years) | ||||
| Median | 53 | 52 | 64 | 55 |
| IQR | 43–64 | 37–63 | 57–73 | 52–69 |
| Adnexal histology | ||||
| Benign | ||||
| Cystadenoma | 21 | – | – | – |
| Cystadenofibroma | 52 | – | – | – |
| Fibrothecoma | 1 | – | – | – |
| Teratoma | 25 | – | – | – |
| Leiomyoma | 13 | – | – | – |
| Other | 18 | – | – | – |
| Borderline | ||||
| Serous | – | 22 | – | – |
| Mucinous | – | 15 | – | – |
| Other | – | 4 | – | – |
| Invasive | ||||
| High-grade serous | – | – | 62 | – |
| Low-grade serous | – | – | 6 | – |
| Mucinous | – | – | 8 | – |
| Endometrioid | – | – | 9 | – |
| Clear-cell | – | – | 3 | – |
| Non-epithelial | – | – | 4 | – |
| Metastasis | ||||
| Gastric cancer | – | – | – | 3 |
| Other | – | – | – | 5 |
| FIGO stage | ||||
| IA | – | 30 | 15 | – |
| IB | – | 3 | – | – |
| IC | – | 3 | 8 | – |
| IIA | – | 1 | 1 | – |
| IIB | – | 1 | 2 | – |
| IIIA | – | 2 | 4 | – |
| IIIB | – | 1 | 8 | – |
| IIIC | – | – | 22 | – |
| IVB | – | – | 32 | – |
| CA-125 (in kU/L) | ||||
| Median | 20 | 30 | 206 | 37 |
| IQR | 12–34 | 18–109 | 63–643 | 23–91 |